LOEROP JAMES (Chief Business Officer) exercised options at ACLARIS THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/5/2026ACC: 0001781549-26-000011
Officer· Chief Business Officer
Since Jan 2022
-5.94K
Net shares
Net seller
$20.6K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
20.88K acquired · 26.81K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20.88K
Price / share
—
Trade value
—
% of position
11.8%
2/3/2026
177.32K→198.20K
Common Stock
Direct
Shares
−5.94K
Price / share
$3.47
Trade value
$20.60K
% of position
3.0%
2/3/2026
198.20K→192.26K
Total
Net shares
+14.94K
Net value
-$20.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2026 | M · Option Exercise | +20.88K | — | — | 11.8% | 177.32K | 198.20K |
| Common Stock Direct | 2/3/2026 | F · Tax Withholding | −5.94K | $3.47 | $20.60K | 3.0% | 198.20K | 192.26K |
| Total | +14.94K | -$20.60K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
20.88K shares
Shares
−20.88K
Strike price
Held after
62.63K
Exercisable
—
2/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock20.88K shares | 2/3/2026 | M · Option Exercise | −20.88K | — | 62.63K |